Health Canada Approves Novartis' Tabrecta for NSCLC With METEx14 Skipping Alterations
The Canadian approval follows similar decisions in the US and Japan, and a positive recommendation from the EMA's CHMP.
Source: precisiononcologynews.com
Shem Singh News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Shem Singh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Shem Singh Today - Breaking & Trending Today
TECENTRIQ (atezolizumab) authorized for Canadians with early non-small cell lung cancer
Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 14, 2022, Health Canada has authorized TECENTRIQ® (atezolizumab) as - Click here if this is your press release! - Travel News | eTurboNews | eTN
Source: eturbonews.com